Trastuzumab modified silica nanoparticles loaded with doxorubicin for targeted and synergic therapy of breast cancer
- Type
- Expression of concern
- Notice date
- 4/26/2022 0:00
- Journal
- Artificial Cells, Nanomedicine, and Biotechnology
- Publisher
- Taylor and Francis
- Notice DOI
- 10.1080/21691401.2022.2054523
- Original paper DOI
- 10.1080/21691401.2018.1501380